Hepatitis prevention in the context of HIV prevention point work in Latvia

Similar documents
Review on HIV & Associated Infections in Latvia

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

Trends of HIV/AIDS in LATVIA. Inga Upmace, Infectology Center of Latvia, AIDS Program Department Saariselka,

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros

The evolution of the HIV/AIDS outbreak among IDUs in Romania

Technical Guidance Note for Global Fund HIV Proposals

NSPs in Estonia: current situation and future challenges

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

HIV epidemic around the Baltic Sea

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

UNGASS COUNTRY PROGRESS REPORT LATVIA

THE PORTUGUESE COMMUNITY SCREENING NETWORK

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES

Additional North Carolina Projects

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

COUNTRY TABLE. MONTENEGRO.

Models of good practice in drug treatment in Europe. Project group

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Harms and harm reduction workbook. Country X

Government of Canada Federal AIDS Initiative Milestones

TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015

Methods: respondent driven sampling (RDS) was used to recruit PWID

Strategies of drug users to avoid infection with hepatitis C

January Treatment Centre. December Drop-In Centre. November Regional Office

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

ATLAS on substance use 2017:

epidemic among vulnerable groups

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas

World Health Organization. A Sustainable Health Sector

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups

QuADS Organisational Standards and Professional Competencies in needle exchange

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

HIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS

STI and HIV Prevention and Care among Sex Workers

SAULIUS ČAPLINSKAS MD, PhD

Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites.

Primary and secondary hepatitis prevention and control programmes The Netherlands

Viral Hepatitis. WHO Regional Office for Europe July 2013

Formative Research results

Promoting hepatitis B vaccination

Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference

Poland nationalupdate

Access to needle and syringe exchange services in Estonia

Situation with HIV prevention among MSM in Latvia

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

SUMMARY OF INTERIM REPORT

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies

No Wrong Door Integrative Screener 1.0 Feedback Sheet 01/14/15

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

Needle exchange programs

Request for Proposals for a Clean Syringe Exchange Program

HIV, HBV and HCV testing policy experiences and lessons learned.

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Prevention Point Philadelphia

FIGHTING HIV IN ESTONIA IN 2006 AND Aire Trummal, Liilia Lõhmus, Kristi Rüütel

THE REPUBLIC OF BELARUS

China Country Advocacy Brief Injecting Drug Use and HIV

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EG on Prison Health Third Meeting Paris France June 2007

In 1993 and 1996, 1 percent of IV drug users tested were positive. In 2000, 193 injecting drug users were screened and none tested positive.

Getting There: Community Policing to Police Social Responsibility Law enforcement & HIV prevention

Building a New Approach to Health Care Services for Hard to Reach Clients

OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan

POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)

Public drug policies Catalonia

Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Prevention of and Immunisation against Hepatitis B and C

Figure 1: Newly diagnosed HIV-cases and total number of HIV-cases, (Data source: Estonian Health Board)

Drug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations

As a result of this training, participants will be able to:

Background: Kirketon Road Centre

Harm reduction among drug users in Spain

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

Achieving the first 90 and doing it right

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Drug Use, Prisons and Compulsory Drug Treatment Centers

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

2004 Update. Georgia

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

TARGET INTERVENTION (SIMS Reporting Indicator Definitions)

Reducing Harm or Producing Harm? Public Health Implications of Prosecuting HIV-positive People. Warren Michelow

increased efficiency. 27, 20

Guidelines For Services Providing Injecting Equipment

Harm Reduction in Nigeria

Background. Population/Intervention(s)/ Comparison/Outcome(s) (PICO)

As a result of this training, participants will be able to:

FDAP Drug & Alcohol Professional Certification Workplace Assessment

Hepatitis and HIV Co-Infection: Situation in Ukraine.

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Transcription:

Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205.

HIV prevention point network in Latvia: History; Location; Financing and legal status; Types of service; Target groups; Data collection. Hepatitis B and C prevention: Hepatitis B and C prevalence in risk groups; Hepatitis B and C rapid testing results; Rapid testing algorithm; World Hepatitis day activities 205. 2

HIV prevention point network and harm reduction in Latvia 3

History of HIV prevention point services in Latvia In 997 first needle exchange programme (NEP) in Riga In 999 - first outreach workers were involved in prevention activities In 2000 NEP was extended to two other cities In 2002 new 8 NEP (external funding) In 204 one new HPP opened(ventspils city) In the beginning of 205 - The Checkpoint (for men who have sex with men (MSM)) 205- there are 9 HIV prevention services in 6 cities in Latvia. Including 3 mobile units, outreach work in 7 cities. 4

9 HPP in 6 municipalities - Municipalities where is HPP 5

Legal status of HPP and financing agreements Municipalities Coordinator HIV/AIDS CR GO budget Project budget Methodological guidance Trainings Data analysis NGO s Coordinators of municipalities Municipalities budget Project budget Services for clients (testing, counseling etc) Salaries for staff Data collection Medical facilities (rapid tests, syringes, disinfectants, condoms etc.) Public utilities payments 6

HIV prevention point - types of service Fixed place for service (HIV/AIDS consulting room); Mobile unite programme (minibuses); Outreach work programme. 7

HIV prevention point in Ogre

Target groups of HIV prevention services.drug-users Users of opiates; Users of cocaine and stimulants; Women drug-users; Minor drug-users; Ex-prisoners drug-users; Persons who involved in commercial sex drug-users and etc. 2.Men who have sex with men 3.Persons with other addiction problems 9

HIV prevention services for IDU'S and other HIV risk groups. Needle and syringe exchange 2. Supply with disinfectants, condoms and other medical facilities 3. Counselling and information (medical worker, social worker, psychologist) about: drug adiction treatment and rehabilitation; health risks related to drug injection and safe drug injection practice; social support; infectious disease and prevention measures; psychological support; counselling of family members and partners. 4. Rapid testing: HIV, HBV, HCV, syphilis 0

Data collection - electronic data base (202) Demographic information: Gender, age, nationality, education level. Injecting behaviour: Ever, how often, last drug use. Status: IDU, SW, ex-prisoner, pregnancy, HIV+ etc. Consultation: infectious disease, STI, motivation, rehabilitation, treatment etc. Medical facilities: performed rapid tests, distributed syringes,needles, condoms etc.

Hepatitis B and C prevention 2

Hepatitis B and C prevalence in the HIV risk groups (study results) Risk group Prevalnce of hepatitis B Prevalence of hepatitis C Year Reaserch Drug users 3,0% 83,7% 203 7th wave of Riga Drug User s Cohort Study (RDUCS) Drug users 2,4% 83,3% 202 6th wave of Riga Drug User s Cohort Study (RDUCS) Sex workers 47,0% 58,% 202 «HIV infection, other infections and associated risk factor identification in one of the HIV infection risk group commercial sex workers» Prisoners 7,0%* 34,0%* 204 «Research on drug prevalence in prisons of Latvia in 204» *during the last year of those prisoners who carried out the blood test 3

Rapid testing algorithm in HIV prevention points Pre-test counselling: a) testing experience; b) reason of testing/ process / «window period»; c) risk assessment of infection; d) information / education / prevention regarding hepatitis Client s informed consent Rapid testing - + Post-test counselling Health risks Retesting after time («window» period) Post-test counselling Implecations of positive test result; Confirmatory diagnostic (Infectology centre); Psyhological and emotianl support. 30 minutes 4

Hepatits B rapid testing results in HIV prevention points, 200-204 (drug users) P=,5% P=2,% P=2,0% P=3,7% 5

Hepatits C rapid testing results in HIV prevention points, 200-204 (drug users) P=54,4% P=59,2% P=72,9% P=29,0% P=37,9% 6

Hepatitis prevention activities in HIV prevention points» World Tuberculosis day (24 March);» World Hepatitis day (28 July);» HIV testing week (one week before World AIDS day);» World AIDS day ( December). 7

World Hepatitis day activities 205 (27 July August) Open days in HIV prevention points (0) and in Red Cross of Latvia Health rooms (2); Rapid testing activities (hepatitis, HIV, syphilis); Specialist consultations about heaptitis and other infections; Passing out flyers; Information in social networks (facebook, twitter, homepages); Informative materials. Performed: 04 Hepatits C rapid tests (+49) 390 Hepatitis B rapid tests (+6) 224 HIV rapid tests (+) 9 Syphilis rapid tests (+) 8

Informative materials Flayer Fact sheet in social network Testing calendar 9

Informative materials Booklet HIV/AIDS, hepatitis B and C, STI s Brochure hepatitis C Posters 2 0

THANK YOU